In 2021, Deaf or hard of hearing (DHH) persons made up ~3.4% of the United States population however, there was no sub-categorical data about race. This dearth of data makes it challenging to quantify the health disparities amongst Black DHH individuals. This paper aims to identify trends and disparities to improve health outcomes for DHH and Black patients seeking dermatologic care. Black patients utilize less preventative service, have lower post-trauma survival, and a 3-fold higher risk of maternal mortality than White patients. DHH patients experience delayed cancer treatment, more emergency department visits, and higher intimate partner violence than hearing patients. Black DHH patients have a higher likelihood of cancer, diabetes, hypertension, and lung disease than Black-hearing patients. Black patients have lower survival rates with certain cutaneous neoplasms and poorer disease control than White counterparts. The literature lacks dermatologic care outcomes for Black DHH patients. Shared themes impacting Black and DHH patients’ care include audism and racism, medical mistrust, and poor communication with clinicians. Unfortunately, the dermatological experiences of Black DHH patients are poorly documented. To minimize disparities for this population, clinicians must acknowledge them and partner with the community to investigate them.
Statements and Declarations: No financial or non-financial interests to disclose.